Retail

Bridal Cosmetics E-Commerce Luxury Office Products Supply Chain Management
News Release Digital Asset Direct

Emergent Health and Apollo Biowellness Announce Strategic Collaboration

Emergent Health Corp.

Emergent Health Corp. (OTC: EMGE), a curator, developer, and marketer of products in the Regenerative Health Space announced today that it will be collaborating with Apollo Biowellness, Inc., the entity that Boustead has engaged to conduct an IPO of the roll up of the regenerative medicine space, previously announced by Emergent on May 18, 2023. Apollo is an aggregate of manufacturing, distribution and marketing of regenerative products and brands in the regenerative space. This partnership, along with the previously announced spin-off of PharmaZu will continue to build significant value to Emergent. As part of the roll-up being conducted by Boustead and Apollo Biowellness, effective June 1, 2023, Mr. Morrison will take over as President/CEO of Apollo Biowellness. Mr. Morrison will remain as a member of the Board of Directors of the Emergent and will assume the Title of Chairman of the Board. He will continue to be intimately involved with Emergent and the continued development, marketing and distribution of its products and brands, The two companies will coordinate marketing strategies, manufacturing and work together to expand the products and brands. Jim Morrison stated, “Since taking the helm of Emergent, I have enjoyed the process of creating the Company’s vibrant products and brands in the regenerative biologic space. The opportunity to coordinate between Emergent and Apollo and expand the value of these products and brands as President of Apollo Biowellness is an exciting opportunity and will bring expanded value to Emergent. I look forward to continuing to be involved in the dynamic offerings of Emergent going forward.” Jim Zimbler, a member of the Board of Directors, and previously the President of the Company, has been re-appointed as Interim President of the Company, also effective June 1, 2023. In addition to bringing on new senior management, the Company will be announcing a new CFO and a will conduct a new executive search for a new permanent full time CEO to work with the current management and Board and team and Mr. Morrison and the Apollo Biowellness team. The Company will announce more Management updates shortly. Jim Zimbler stated, “Jim Morrison has done a magnificent job during his tenure as President, and I know he will be a tremendous asset to Apollo Biowellness. I look forward to a close continued relationship with Mr. Morrison and leaning on him for his sizable experience and tutelage related to products and brands. That will greatly enhance the value Emergent will receive from the sale of Evolutionary Biologics and the other entities.” ABOUT EMERGENT HEALTH CORPORATION Emergent curates, develops and sells products in the Regenerative Health Space. Its products comprise of ingestibles as well as topicals for the whole family. The company distributes its products online and through Content Based Shopping using Influencers to position products in their produced content throughout the United States and Internationally. Its subsidiaries; PharmaZu, is a pure play, e-commerce products and service provider focused on the Pet Community, Pet Pharmacy and Pet Wellness using Influencers and their content, including the pet pharmacy, vet telehealth and pet wellness businesses. Evolutionary Biologics, is a new kind of biologics company founded for a clear purpose: bring cutting edge regenerative products to the medical community. Emergent does not claim any of its products are approved by the FDA to diagnose, treat, cure or prevent any disease. For more information, please visit Emergent's Website and Social Media on Twitter. Before using any products, you should always consult with your Veterinarian and/or Family Doctor. SAFE HARBOR STATEMENT This press release contains forward-looking statements that can be identified by terminology such as “believes,” “expects,” “potential,” “plans,” “suggests,” “may,” “should,” “could,” “intends,” or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results implied by such statements. These factors include, but are not limited to, our ability to continue to enhance our products and systems to address industry changes, our ability to expand our customer base and retain existing customers, our ability to effectively compete in our market segment, the lack of public information on our company, our ability to raise sufficient capital to fund our business, operations, our ability to continue as a going concern, and a limited public market for our common stock, among other risks. Many factors are difficult to predict accurately and are generally beyond the company's control. Forward-looking statements speak only as to the date they are made, and we do not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made. FOR MORE INFORMATION, PLEASE CONTACT: Jim Morrison, Chairman of the Board James W. Zimbler – Interim President/Interim CEO Emergent Health Corporation Website i nfo@emergenthealthcompany.com Contact Details Emergent Health Corp. info@emergenthealthcompany.com Company Website https://emergenthealthcompany.com/

May 23, 2023 09:00 AM Eastern Daylight Time

NextTech3D.ai discusses record-breaking growth and AI-generated 3D model deliveries

Nextech3D.AI

NextTech3D.ai CEO and Founder Evan Gappelberg joins Natalie Stoberman from the Proactive studios to share the company's record financial and operational results for the first quarter of 2023. Gappelberg says NextTech3D.ai has experienced significant growth which saw a 550% year-over-year surge in its 3D modeling business. The company has also reported 40% sequential revenue growth, while delivering 20,000 3D models to Amazon, their largest customer. Gappelberg says he attributes the company's explosive growth to Amazon's influence and their ability to generate 3D models at a lower cost and higher volume using generative AI. Contact Details Proactive Investors Canada +1 604-688-8158 na-editorial@proactiveinvestors.com

May 22, 2023 02:01 PM Eastern Daylight Time

Video

Nextech3D.AI adds $2 million in growth capital cash from fintech firm Ratio Technology

Nextech3D.AI

Nextech3D.AI CEO Evan Gappelberg joined Steve Darling from Proactive to share news the company has received an initial $2 million infusion without share dilution by doing a deal with fintech firm Ratio Technology and its $400 million credit fund. Gappelberg telling Proactive the $2 million in cash was paid against future invoices that the company has contracts for but has not yet been paid. It feels this new access to non-dilutive capital on these long-dated purchase orders will enhance its financial flexibility. The company's strong customer contracts, including blue-chip clients like Amazon and Kohl's, contribute to its ability to secure long-dated contracts and attract substantial funding. Contact Details Proactive Investors Canada +1 604-688-8158 na-editorial@proactiveinvestors.com

May 22, 2023 01:22 PM Eastern Daylight Time

Video

Shareholder to Address Censorship Policies at Alphabet, Amazon, and Meta

National Legal & Policy Center

Following the exposure by the “Twitter Files” reports that revealed the extent to which malicious government agencies colluded with Big Tech to censor content, a shareholder in three Silicon Valley corporations will present proposals in the coming weeks to address their suppression of speech. National Legal and Policy Center – which owns stock in Amazon, Alphabet (parent of Google and YouTube) and Meta (parent of Facebook) – will sponsor proposals at each company that request transparency about requests they have received from U.S. government officials to “take down” content from their platforms. Amazon’s annual meeting is on Wednesday, May 24; Meta’s is on May 31, and Alphabet’s is on June 2. “As we’ve learned since Elon Musk took over Twitter, there is an epidemic of unconstitutional government censorship of speech in our country, and Big Tech has welcomed the opportunities to be their enforcers,” said Paul Chesser, director of NLPC’s Corporate Integrity Project, who will present the proposals at the companies’ respective meetings. “It is vital, as public companies, that Alphabet, Amazon and Meta act in the country’s interest and disclose who in the federal government is making these improper – and most of them probably illegal – requests, and divulge what they have asked to be removed from their platforms.” The Amazon and Meta proposals seek an itemization of the requests the companies have received from federal government. The Alphabet proposal asks for a report about the extent its censorship policies and practices have on the fiduciary health of the company. The text of NLPC’s proposal for a “Risk Audit on Content Censorship” for Alphabet’s 2023 annual meeting follows: RESOLVED: Shareholders request that Alphabet Inc. (“Company”) issue a report at reasonable cost – omitting proprietary or legally privileged information – reviewing the vulnerabilities of its enforcement of Google’s and YouTube’s Terms of Service related to content policies, and assessing the risks posed by content management controversies related to issues such as election interference, freedom of expression, and inequitable application of policies, and how they affect the Company’s finances, operations, and reputation. SUPPORTING STATEMENT: Evidence has accumulated over many years that show Alphabet Inc.’s platforms discriminate against disfavored speech, interfered in elections, and is undeniably prejudiced. Major examples include: In leaked Company emails, employees discussed using “ephemeral experiences” to change users’ views. Back in 2016, the Company’s chief financial officer said, “we will use the great strength and resources and reach we have” to advance Google’s values. Consequentially, senior research psychologist Dr. Robert Epstein found that – based on 1.5 million search experiences his team aggregated in 2020 – that the Company’s manipulations could have shifted up to six million votes to Joe Biden. A study of voter outreach by 2020 political candidates, conducted by North Carolina State University’s Department of Computer Science, found that Google’s Gmail “marked 59.3% more emails from [conservative] candidates as spam compared to the [progressive] candidates.” The Republican National Committee claimed that Gmail sent more than 22 million of its emails to spam during a critical fundraising period in the 2022 election cycle. The Company has incurred a lawsuit and a complaint to the Federal Elections Commission due to the alleged suppression. A Media Research Center analysis of the most tightly contested 2022 U.S. Senate races found that ten of 12 Republican candidates’ campaign websites (83%) appeared far lower (or did not appear at all) on page one of Google’s organic search results, compared to their Senate Democratic Party opponents’ campaign websites. In addition to the above examples, the Company is the target of a credible, major lawsuit by the states of Missouri and Louisiana, based on extensive evidence that the Company violated users’ First Amendment rights. Shareholders need to know whether the Company is engaged in unconstitutional censorship, and whether the Company exercises its content moderation in violation of its Terms of Service, opening the Company to liability claims by victims. Shareholders also need to know whether the Company is failing to disclose these potential liabilities as material risks in its public filings. There is currently no single source providing shareholders the information sought by this resolution. Founded in 1991, NLPC promotes ethics in public life and government accountability through research, investigation, education, and legal action. ### For more information or to schedule an interview with Paul Chesser, contact Dan Rene at 202-329-8357 or drene@nlpc.org. Please visit http://www.nlpc.org. Contact Details National Legal and Policy Center Dan Rene +1 202-329-8357 drene@nlpc.org Company Website http://www.nlpc.org

May 22, 2023 10:00 AM Eastern Daylight Time

Emergent Health Executes Term Sheet and Engagement Letter with Boustead Securities to roll up its Subsidiary, Evolutionary Biologics and other regenerative medicine and products companies

Emergent Health Corp.

Emergent Health Corp. (OTC: EMGE), a curator, developer, and marketer of products in the Regenerative Health Space announced that it has executed a Term Sheet and Engagement Letter with Boustead Securities to roll up its subsidiary Evolutionary Biologics and other regenerative medicine and regenerative biologic products companies with NO DILUTION to the Emergent Shareholders with a planned $10 million initial capital raise and public offering and application for listing on NASDAQ or NYSE/AMEX. Emergent’s subsidiary, Evolutionary Biologics, and the new brand called Maximus Men’s Health, along with Juventix Regenerative Medical and Interactive Practice Solutions and Nanosthetic. Subsequent to the IPO, Emergent plans to distribute the shares received by Emergent from the sale of Evolutionary Biologics as a dividend to its shareholders, pro rata at NO COST to the Emergent Shareholders. Such a dividend would only occur after Emergent files a Registration Statement with the SEC and it is declared effective. Any potential taxable event resulting from such a dividend would be the responsibility of each individual shareholder, and Emergent advises each shareholder to consult with their professional advisors, and makes no representation as to the taxable or nontaxable event. Evolutionary Biologics, is a new kind of biologics company founded for a clear purpose: bring cutting edge regenerative products to the medical community. Emergent does not claim any of its products are approved by the FDA to diagnose, treat, cure or prevent any disease. Jim Morrison, former L'Oréal President and Emergent’s full time CEO stated, “Boustead Securities is a world class financial organization. They approached us to participate in rolling up a series of regenerative biologics into a brand-new IPO. When you look at the effect that this transaction, and the previously announced PharmaZu transaction, will have on EMGE, it's amazing. We see this as a great way to maximize valuation for our Company and take EMGE to the next level.” ABOUT EMERGENT HEALTH CORPORATION Emergent curates, develops and sells products in the Regenerative Health Space. Its products comprise of ingestibles as well as topicals for the whole family. The company distributes its products online and through Content Based Shopping using Influencers to position products in their produced content throughout the United States and Internationally. Its subsidiaries; PharmaZu, is a pure play, e-commerce products and service provider focused on the Pet Community, Pet Pharmacy and Pet Wellness using Influencers and their content, including the pet pharmacy, vet telehealth and pet wellness businesses. Evolutionary Biologics, is a new kind of biologics company founded for a clear purpose: bring cutting edge regenerative products to the medical community. Emergent does not claim any of its products are approved by the FDA to diagnose, treat, cure or prevent any disease. For more information, please visit Emergent's Website and Social Media on Twitter. Before using any products, you should always consult with your Veterinarian and/or Family Doctor. SAFE HARBOR STATEMENT This press release contains forward-looking statements that can be identified by terminology such as “believes,” “expects,” “potential,” “plans,” “suggests,” “may,” “should,” “could,” “intends,” or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results implied by such statements. These factors include, but are not limited to, our ability to continue to enhance our products and systems to address industry changes, our ability to expand our customer base and retain existing customers, our ability to effectively compete in our market segment, the lack of public information on our company, our ability to raise sufficient capital to fund our business, operations, our ability to continue as a going concern, and a limited public market for our common stock, among other risks. Many factors are difficult to predict accurately and are generally beyond the company's control. Forward-looking statements speak only as to the date they are made, and we do not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made. FOR MORE INFORMATION, PLEASE CONTACT: Jim Morrison, CEO Emergent Health Corporation Website info@emergenthealthcompany.com Contact Details Emergent Health Corp. info@emergenthealthcompany.com Company Website https://emergenthealthcompany.com/

May 18, 2023 09:00 AM Eastern Daylight Time

Image

Nextech3D.AI hits major milestone delivering over 20,000 3D models to Amazon

Nextech3D.AI

Nextech3D.AI CEO Evan Gappelberg joined Steve Darling from Proactive to share news the company achieved a major milestone producing over 20,000 thousand models with its preferred model supplier deal with Amazon. Gappelberg also shared with Proactive the company has scored a renewal contract with the largest department store in the United States for 5,000 3D models. Discussion are underway to increase that contract as well. Contact Details Proactive Investors Canada +1 604-688-8158 na-editorial@proactiveinvestors.com

May 17, 2023 08:24 AM Eastern Daylight Time

Video

Singaporean Telehealth Platform ORA Raises $10 Million Series A to Modernise Healthcare in the Region

ORA

Singaporean telehealth platform ORA has raised a $10 million USD Series A funding. This is the largest telehealth Series A in South-East Asia and was co-led by TNB Aura and Antler with participation from Gobi Partners, Kairous Capital and GMA Ventures, bringing total funding to date above $17 million USD. ORA is the fastest-growing and biggest vertically-integrated telehealth platform in South East Asia delivering over 250,000 consultations and has experienced uninterrupted monthly growth since its 2021 launch. ORA has launched three brands that serve the modern patient living with chronic conditions, making treatment more accessible, convenient and personal. Modules is a first to market online dermatology experience making personalised, prescription skincare accessible with 676 different formulations, andSons offers male health solutions and OVA delivers female reproductive healthcare. Founded by former ZALORA CMO Elias Pour, ORA is uniquely positioned with a diverse, proven leadership team with rich backgrounds across health, tech and consumer brands. Backed by a robust medical advisory board, ORA’s R&D team draws on experience from L’Oréal and Sephora creating high-touch products and experiences that are IP’d and 100% in-house developed. With a strong attention to customer experience, first to market solutions like Modules, andSons and Ova are meeting modern customer expectations head on. These interactions are translating into deeper patient relationships, building retention rates only rivalled by subscription models like Netflix and unrivalled within the industry. 90% of ORA’s patients are first to condition, under 38 years old and have never been treated before. The disconnect between this younger patient population and the traditional healthcare model is ORA’s biggest opportunity. These new patients have a different set of demands such as flexibility and speed which ORA’s telemedicine model is perfectly placed to treat. ORA’s seamless end-to-end experience joins up the fragmented traditional model, linking consultation, education, pharmacy, delivery and post purchase care for unparalleled convenience. “ORA is on a mission to deliver high touch, high-quality care to millions of patients and with our continued growth story throughout SEA, we are thrilled with today's announcement.” said Elias Pour, ORA’s founder and CEO. “ORA has had over 6 million patient touch points provide us with valuable health data through extensive health evaluations and consultation online. This has brought unique insights into these patient’s healthcare expectations that has and will inform future innovations with our key partners.” “We have the high growth potential of DTC, with a very high percentage of healthcare expenditure in our region being out of pocket. This is powered by an underlying SAAS type of recurring revenue, with subscriptions counting for more than 70% of our revenue and our retention is better than Netflix with 10x the monthly order value. We achieved post marketing breakeven at the end of last year on a group level after just 20 months of going live and have a very clear and believable path to profitability that is imminently ahead of us. With this new round of funding ORA will seek to expand its presence into new territories, both geographically and with new offerings. Later this year ORA’s brands will arrive in retail across 1300 tier one stores bringing its accessible, medically-backed range of products to shelves. Looking at different geographies there are opportunities to expand into regions like the GCC. Charles Wong, Founding Partner at TNB Aura commented: “Since ORA’s early days, TNB Aura has been a firm believer and strong supporter of Elias and the ORA team in their unwavering mission to provide access to affordable high-quality healthcare. Their combined focus on specialised, and often taboo, healthcare verticals as well as a direct-to-patient approach has led the team to clearly differentiate itself while delivering market-leading unit economics that meet the tailored needs of patients across the full value chain.” Teddy Himler - Global Partner at Antler added: “Elias and team have learned from the extraordinary rise of telehealth globally and have applied it masterfully to the idiosyncratic (and often challenging) South East Asia region. We are inspired and supportive of their mission to become the “ Healthcare House of Brands” for the ~1B people in South East Asia and GCC who are underserved by the traditional healthcare system. We think ORA’s platform approach is the future of direct-to-patient healthcare globally.” About ORA ORA is a house of healthcare brands powered by a vertically integrated telehealth platform. Founded in 2020 by ex ZALORA CMO Elias Pour, it is now SEA’s fastest growing digital health provider operating in Singapore, Malaysia and the Philippines with additional markets being launched during the rest of 2023. Its growing portfolio of healthcare brands includes Modules (prescription skincare), OVA (women’s health) and andSons (men’s health). Their HQ is located in Singapore. About TNB Aura At TNB Aura, we are investing in and helping to build the future of Southeast Asia. As a thesis-led, high-conviction venture capital firm, we use data-driven methodologies to identify and invest in select companies that are primed for the future and ready to change the very face of their categories. An approved co-investment partner of Enterprise Singapore, we invest US$2-10 million into Series A and B tech startups - and beyond that, we become true partners in their quest to uplift lives of The Next Billion. About Antler Antler is the investor backing the world’s most driven founders from day zero to greatness. Founded on the belief that people innovating is the key to building a better future, we partner with people across six continents to launch and scale high-potential startups that address meaningful opportunities and challenges. Knowing that exceptional founders can come from anywhere with any background, we have offices in 25 cities, including Austin, New York, London, Berlin, Stockholm, Bangalore, Jakarta, Singapore, Seoul, Tokyo, and Sydney. Our global community backs people from the beginning with co-founder matching, deep business model validation, initial capital, expansion support, and follow-on funding. Fueled by a personal passion that goes beyond traditional investing, we have helped create and invested in more than 750 startups across a wide range of industries and technologies, with the goal of backing more than 6,000 by 2030. Contact Details ORA Bilal Mahmood +44 7714 007257 b.mahmood@stockwoodstrategy.com Company Website https://www.ora.group/

May 17, 2023 07:00 AM Eastern Daylight Time

Image

More Than Just a Room: How Airbnb Can Help You Travel Like a Local -- on a Budget

YourUpdateTV

Want to travel like a local, but on a budget? Airbnb is a great option for those looking to experience a destination authentically without breaking the bank. Recently, Airbnb Superhosts, Rhonda Voo and Eric Alan conducted a satellite media tour to talk about their experience being Airbnb hosts and how it helped them connect with people and have authentic experiences. A video accompanying this announcement is available at: https://youtu.be/6OnoHquTFMg In the current economic environment, people want to travel affordably. And after years of being isolated during the pandemic, they're looking for ways to connect with people and have authentic experiences. With the pandemic finally over, this summer is anticipated to be the biggest travel season of all time. Airbnb is expecting a record 300 million people to travel and host on Airbnb this year. To prepare, Airbnb is making the most extensive set of improvements to the platform ever, starting with the introduction of Airbnb Rooms, an all-new take on the original Airbnb. They’re also launching over 50 new features and upgrades that address top feedback from our guests and Hosts across the end-to-end Airbnb experience. Introducing Airbnb Rooms Airbnb began as a way to stay in a room in someone else’s home. This original idea of sharing a home offers two unique benefits. First, it’s more affordable for guests. More than 80% of private rooms are under $100/night, with an average rate of $67/night. Second, staying with a Host is a great way to meet someone new and experience the city like a local. In the current economic environment, people want to travel affordably. And after years of being isolated during the pandemic, they're looking for ways to connect with people and have authentic experiences. Now is the perfect time to stay in a room in someone else’s home. But for even more people to try it, they have to feel comfortable staying with a Host. Airbnb Rooms, an all-new take on the original Airbnb. Guests have told us that they want to know more about who they're staying with. Every Airbnb Room features a Host Passport, which helps guests get to know their Host before booking their stay. Airbnb has also created a Rooms category with over 1 million listings, redesigned filters and added new privacy features. 50+ new features and upgrades based on Hosts and Guests feedback: In preparation for an anticipated record-setting travel season, Airbnb is improving nearly every aspect of their service, here are some of the upgrades: Host Passport - Exclusive to Airbnb Rooms, the Host Passport helps you get to know your Host before booking your stay. Simply tap the Host Passport to view a larger photo and details Hosts have shared about themselves, including where they went to school, what they do for work, a fun fact about themselves, the amount of social interaction during the stay, and much more. Airbnb Rooms category - Airbnb Rooms are easy to discover, with a new category featuring a curated set of 1 million private bedrooms. Each listing includes access to shared spaces, such as the kitchen, living room, and backyard. Redesigned filters - Redesigned the “type of place” filter to make it easy to switch between Airbnb Rooms, entire homes, or all types of places. It’s simple to view the average price for each type of place with an enhanced price filter that updates based on your choice. New privacy features - Privacy is important. All Airbnb Rooms will clearly indicate if the bedroom door has a lock. The listing page also shows whether the bathrooms are shared or private, and whether people other than the Host will be in the home during your stay. To improve our service, Airbnb took a design-driven approach. They started by storyboarding the guest and Host journey - from sign up to checking out and created a blueprint of the experience - every screen, every policy, and every interaction with customer support mapped out. Then, analyzed millions of customer service tickets and mapped them across the journey. They also reviewed thousands of social media posts and spoke with hundreds of thousands of guests and Hosts about how to improve Airbnb. To find out more about the Airbnb 2023 Summer Release and how to become a host, visit Airbnb. About Rhonda and Erica Rhonda Voo and Eric Alan are superhosts of a private room in their stunning home in LA. Rhonda and Eric are both creatives at heart, pursuing careers in art and advertising – over the years they transformed their modest home into what is now an architecturally significant landmark in LA. After raising their three daughters, they noticed there was plenty of extra room around the house and decided to open their home to guests on Airbnb. Their experience continues to be rewarding — both financially and personally, making meaningful connections with visitors from around the globe. About Airbnb Airbnb was born in 2007 when two Hosts welcomed three guests to their San Francisco home and has since grown to 4 million Hosts who have welcomed more than 1 billion guest arrivals in almost every country across the globe. Every day, Hosts offer one-of-a-kind stays and unique Experiences that make it possible for guests to experience the world in a more authentic, connected way. Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

May 16, 2023 03:00 PM Eastern Daylight Time

Video

Former L'Oréal President Jim Morrison, Chief Executive Officer of Emergent Health Reports Quarter over Quarter Revenue Increase of Over 2300%

Emergent Health Corp.

Emergent Health Corp. (OTC: EMGE), a curator, developer, and marketer of products in the Regenerative Health Space announced revenues of $340,531 for the quarter ended March 31, 2023, as compared to $14,267 for the quarter ended March 31, 2022, an increase of over 2300%. The financial statement can be viewed in its entirety at https://www.otcmarkets.com/stock/EMGE/disclosure. Jim Morrison, former L'Oréal President and Emergent’s full time CEO stated "Q1 was a good starting point for the 'new look' EMGE. You will see the effect of many of our new business initiatives as we move into the second quarter and throughout the year. We are on track for 2023 to be a very good year." Emergent believes it will continue increasing its revenues quarter over quarter as it expands its business internally and externally through acquisition. Recent Developments: On May 11, 2023, announced that its subsidiary Evolutionary Biologics, Inc. (EvoBio), a developer, manufacturer and distributor of private label regenerative medicine products and branded state-of-the-art biologic products, created in a pharmaceutical grade laboratory and manufacturing facility has executed a Product Manufacturing Agreement with a distributor of medical devices that desires to market a MSC Exosome product from EvoBio as a private label on an exclusive basis. The Company believes the new relationship will generate at least $2 million in new revenue. The press release can be viewed in its entirety here. On May 9, 2023, announced that it has engaged BF Borgers CPA PC, a full-service audit, tax, accounting, and advisory firm, as its Public Company Accounting Oversight Board (PCAOB) qualified auditor to audit the Company’s financial statement for the two-year period ending December 31 st, 2022 according to Generally Accepted Accounting Principles (GAAP). GAAP is the accounting standard adopted by the Securities and Exchange Commission (SEC) and is the default accounting standard used by companies based in the United States. The press release can be viewed in its entirety here. On May 4, 2023, announced the execution of an Engagement Letter with Boustead Securities LLC. to act as exclusive financial advisor with respect to a planned corporate financing transaction including the private placement of securities (pre-IPO Financing) and a planned $10 million initial public offering of Emergent subsidiary PharmaZu common stock (IPO) that will apply for listing on NASDAQ with NO DILUTION to the Emergent Shareholders. PharmaZu is a pure play, e-commerce products and service provider focused on the Pet Community, Pet Pharmacy and Pet Wellness using Influencers and their content, including pet pharmacy, vet telehealth and pet wellness businesses. Upon the effectiveness of the IPO and listing on NASDAQ, PharmaZu plans to acquire a 49-state authorized compounding pharmacy located in West Palm Beach, FL, doing approximately $10M a year in revenue, which will serve as the backbone and fulfilment center for PharmaZu, creating a national platform throughout the United States. The raise of capital will be used for expanding PharmaZu’s business, product offerings, as well as for acquisitions. Subsequently, Emergent plans to distribute the shares of PharmaZu as a dividend to its shareholders, pro rata at NO COST to the Emergent Shareholders. The press release can be viewed in its entirety here. The global biologics market size was valued at US $366.43 billion in 2021 and it is expected to hit over US$ 719.84 billion by 2030 with a noteworthy CAGR of 7.8% from 2022 to 2030. A biologic medication is a product that is made from live organisms and contains living organism components. Recombinant protein, tissues, allergens, genes, cells, blood components, blood, and vaccinations are all examples of biologics. Anemia, hemophilia, chronic migraine, hepatitis B, rheumatoid arthritis, inflammatory bowel disease, and other disorders and infections are treated with biologics. Various government efforts, higher share of biologics in the market, and rising use of biopharmaceuticals over chemically produced molecules, and many other factors are driving the biologics market expansion in the forecast period. ABOUT EMERGENT HEALTH CORPORATION Emergent curates, develops and sells products in the Regenerative Health Space. Its products comprise of ingestibles as well as topicals for the whole family. The company distributes its products online and through Content Based Shopping using Influencers to position products in their produced content throughout the United States and Internationally. Its subsidiaries; PharmaZu, is a pure play, e-commerce products and service provider focused on the Pet Community, Pet Pharmacy and Pet Wellness using Influencers and their content, including the pet pharmacy, vet telehealth and pet wellness businesses; Regen BioWellness, is a distributor of various products in the plant-based and regenerative medical fields. Evolutionary Biologics, is a new kind of biologics company founded for a clear purpose: bring cutting edge regenerative products to the medical community. Emergent does not claim any of its products are approved by the FDA to diagnose, treat, cure or prevent any disease. For more information, please visit Emergent's Website and Social Media on Twitter. Before using any products, you should always consult with your Veterinarian and/or Family Doctor. SAFE HARBOR STATEMENT This press release contains forward-looking statements that can be identified by terminology such as “believes,” “expects,” “potential,” “plans,” “suggests,” “may,” “should,” “could,” “intends,” or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results implied by such statements. These factors include, but are not limited to, our ability to continue to enhance our products and systems to address industry changes, our ability to expand our customer base and retain existing customers, our ability to effectively compete in our market segment, the lack of public information on our company, our ability to raise sufficient capital to fund our business, operations, our ability to continue as a going concern, and a limited public market for our common stock, among other risks. Many factors are difficult to predict accurately and are generally beyond the company's control. Forward-looking statements speak only as to the date they are made, and we do not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made. FOR MORE INFORMATION, PLEASE CONTACT: Jim Morrison, CEO Emergent Health Corporation Website i nfo@emergenthealthcompany.com Contact Details Emergent Health Corp. info@emergenthealthcompany.com Company Website https://emergenthealthcompany.com/

May 16, 2023 09:00 AM Eastern Daylight Time

1 ... 124 125 126 127 128 ... 245